Source: Prepared Foods

Deerland: Deerland: Digestive Health

Deerland Probiotics & Enzymes announced that the United States Patent and Trademark Office has published its application for a distinct use of Deerland's signature strain DE111® of the probiotic species, Bacillus subtilis DE111® based on compelling human clinicals performed on DE111®.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
250-500
Scott Ravech's photo - CEO of Deerland

CEO

Scott Ravech

CEO Approval Rating

90/100

Read more